RareMed is proud to announce that the company has been recognized on Pittsburgh Business Times’ Fast 50 list as the fastest-growing healthcare company in the Pittsburgh region. This year, RareMed ranked 20th overall out of the top 50 fastest-growing companies in the region, and was only one of 12 companies to make the list in back-to-back years. RareMed’s two-year overall growth rate was 111.39%.
Every year, the Pittsburgh Business Times recognizes the 50 fastest-growing private companies in the Pittsburgh region with this prestigious award. In 2023, the award will highlighted companies with the highest percent growth in revenue between 2020 and 2022. RareMed Solutions leadership attended the award ceremony on August 24, 2023, held at The Westin in Downtown Pittsburgh.
RareMed is excited to celebrate continue this strong growth in what is now the company’s fifth year of operations. This year, the company catalyzed its continued exponential growth with the expansion of its concierge focus from rare diseases to complex prevalent diseases, widening the company’s reach to an entirely new, yet similarly underserved, patient population. To further support their continued growth, the company expanded into a new state-of-the-art facility, specifically designed to fit its growing needs, and house its growing team, well into the future.
Last year, RareMed was ranked as the sixth fastest growing company overall, while similarly taking the top spot in healthcare and technology. RareMed is proud of its ability to continually scale and grow so substantially. We are eagerly looking forward to next year’s Fast 50 Awards, as big things are on the horizon for the company that we cannot wait to share them with our partners and the public.
Chairman and CEO, Dr. Gordon J. Vanscoy commented,
“Being recognized as Pittsburgh’s fastest-growing healthcare company, and one of the fastest overall, by The Pittsburgh Business Times for the second year in a row is validation that the work we are doing as a company is making a difference. We are committed to providing exceptional service and quality of care to our patients, providers, and partners. We strive to deliver continued innovation and aim to remain a disruptor in our field. The RareMed team continues to deliver on its promises of greatness.”
RareMed Solutions is honored to be featured on the Fast 50 list among the other 49 incredible companies and is confident that the company will continue its upward trajectory for years to come.
Join us on our journey to accelerate access to life-altering therapies for patients afflicted with rare and complex conditions. Learn more at www.RareMed.com